PUREGON

This brand name is authorized in Australia, Austria, Canada, Croatia, Cyprus, Estonia, France, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Turkey.

Active ingredients

The drug PUREGON contains one active pharmaceutical ingredient (API):

1	Follitropin beta UNII 076WHW89TW - FOLLITROPIN
	Follitropin beta is a recombinant FSH. Follitropin beta can be used to stimulate follicular development and steroid production in selected cases of disturbed gonadal function. Furthermore follitropin beta can be used to promote multiple follicular development in medically assisted reproduction programs.
	Read more about Follitropin beta

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PUREGON Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03GA06	Follitropin beta	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03G Gonadotropins and other ovulation stimulants → G03GA Gonadotropins
Discover more medicines within G03GA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	6335K, 6336L, 6464F, 8565T, 8566W, 8871X
CA	Health Products and Food Branch	02243948
EE	Ravimiamet	1011913, 1011924, 1011935, 1064045, 1064056, 1064067, 1064078, 1064089, 1064090, 1099335, 1099403, 1209923, 1209934, 1209945, 1209956, 1209967, 1209978, 1209989, 1209990, 1210004, 1215100, 1215111
ES	Centro de información online de medicamentos de la AEMPS	96008025, 96008038, 96008039, 96008041
FR	Base de données publique des médicaments	60727755, 62448341, 65214799, 65393373
HK	Department of Health Drug Office	51208, 51209, 55493
IE	Health Products Regulatory Authority	88761, 88762, 88820, 88833
IL	מִשְׂרַד הַבְּרִיאוּת	4733, 4734, 4965
IT	Agenzia del Farmaco	029520018, 029520020, 029520032, 029520044, 029520057, 029520069, 029520071, 029520083, 029520095, 029520107, 029520119, 029520121, 029520133, 029520145, 029520158, 029520160, 029520172, 029520184, 029520196, 029520208, 029520210, 029520222, 029520234, 029520246, 029520259, 029520261, 029520273, 029520285, 029520297, 029520309, 029520311, 029520323, 029520335, 029520347, 029520350, 029520362, 029520374, 029520386, 029520398, 029520400
LT	Valstybinė vaistų kontrolės tarnyba	1007032, 1007033, 1007034, 1007035, 1007036, 1007037, 1007038, 1007039, 1007040, 1008120, 1008121, 1030534, 1030535, 1030536, 1030537, 1030538, 1030539, 1030540, 1030547, 1030548, 1030549, 1030550
NL	Z-Index G-Standaard	14571420, 14571439, 15033163, 15294072, 15294080
NL	Z-Index G-Standaard, PRK	64270, 64289, 77410, 84034, 84042
NZ	Medicines and Medical Devices Safety Authority	8909
PL	Rejestru Produktów Leczniczych	100103866, 100103872, 100145712, 100145729, 100296500, 100313990, 100314008, 100314014, 100314020, 100314037
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W67765001, W67766001
SG	Health Sciences Authority	12183P, 12184P, 12185P, 14473P, 14474P
TR	İlaç ve Tıbbi Cihaz Kurumu	8683280337367, 8683280337374, 8699636791141
ZA	Health Products Regulatory Authority	32/21.10/0311, 32/21.10/0312, 32/21.10/0313